Evidence map›Paper›PMID 17065185›Full record

Trial reportHeart (British Cardiac Society)2007

Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy.

C L Hu, Y B Li, Y G Zou, J M Zhang, J B Chen, J Liu, Y H Tang, Q Z Tang, C X Huang

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Heart (British Cardiac Society), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Peripartum cardiomyopathy in an intensive care unit setting.World journal of critical care medicine · 2026
    Review
  3. Article
  4. Pharmacological interventions for peripartum cardiomyopathy.The Cochrane database of systematic reviews · 2024
    Article
  5. Diagnosis and management of peripartum cardiomyopathy and recurrence risk.International journal of cardiology. Congenital heart disease · 2024
    Article
  6. Observational
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Peripartum cardiomyopathy.Heart failure reviews · 2021
    Review
  13. Article
  14. Global Left Ventricular Strain at Presentation Is Associated with Subsequent Recovery in Patients with Peripartum Cardiomyopathy.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2019
    Article
  15. Article
  16. Peripartum Cardiomyopathy: an Update.Current heart failure reports · 2018
    Review
  17. Peripartum Cardiomyopathy: a Review for the Clinician.Current treatment options in cardiovascular medicine · 2018
    Review
  18. Article
  19. A contemporary review of peripartum cardiomyopathy.Clinical medicine (London, England) · 2017
    Review
  20. The Role of Cardiac Biomarkers in Pregnancy.Current treatment options in cardiovascular medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

C L HuDepartment of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuchang District, Wuhan, People's Republic of China. chenglinhu@yahoo.com
Y B Li
Y G Zou
J M Zhang
J B Chen
J Liu
Y H Tang
Q Z Tang
C X Huang
Wuhan University · CNWuhan No.1 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether measurement of cardiac troponin T (cTnT) concentration in newly diagnosed peripartum cardiomyopathy (PPCM) can be used to predict persistent left ventricular dysfunction after a 6-month follow-up. PATIENTS AND

methodsThis was a prospective, multiple-centre clinical trial that studied 106 patients with newly diagnosed PPCM surviving over 6 months. cTnT concentration was measured within 2 weeks of the onset of PPCM.

resultsSerum cTnT concentration was negatively correlated with left ventricular ejection fraction (LVEF) at follow-up (LVEF, r = -0.518, p = 0.0001). Analysis by receiver operator characteristic curve yielded an area under the curve of 0.764 (95% CI 0.669 to 0.860, p = 0.0001, vs null hypothesis value 0.5) for cTnT, and a cTnT concentration cut off of >0.04 ng/ml, predicting persistent left ventricular dysfunction with a sensitivity of 54.9% and a specificity of 90.9%. Among 106 recruited patients, there were 33 patients with cTnT concentrations >0.04 ng/ml and 73 patients with cTnT concentrations < or =0.04 ng/ml. After a 6-month follow-up, there was significantly smaller LVEF (35.42% (13.04% vs 50.16% (10.48%, p = 0.0001) and more persistent left ventricular dysfunction (84.8% vs 31.5%, OR = 12.17 (95% CI 4.17 to 35.57), p = 0.001) in patients with cTnT >0.04 ng/ml than in patients with cTnT < or =0.04 ng/ml.

conclusionSerum cTnT concentration measured within 2 weeks of the onset of PPCM was correlated negatively with LVEF at follow-up. This marker offers a simple, quick, inexpensive, non-invasive method for predicting a persistent LVEF of < or =50%. A cTnT concentration of >0.04 ng/ml predicted persistent left ventricular dysfunction with a sensitivity of 54.9% and a specificity of 90.9%.

Indexed as

AdultBiomarkersCardiomyopathiesFemaleHumansPregnancyPregnancy Complications, CardiovascularProspective StudiesPuerperal DisordersROC CurveSensitivity and SpecificityTroponin TVentricular Dysfunction, LeftBiomarkersTroponin T

Identifiers

PMID17065185
PMCPMC1861492
OpenAlexW2166351881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.